Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-25
1989-11-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544279, A61K 31505, C07D47508
Patent
active
048823333
ABSTRACT:
N-alkanoylglutamic acid derivatives in which the alkanoyl group is substituted with the 2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-6-yl or 2,4-diamino-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl group are antineoplastic agents. Typical embodiments are N-[6-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)hexa noyl]-L-glutamic acid and N-[4-{-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl ethyl}cyclohex-1-yl]-L-glutamic acid.
REFERENCES:
patent: 4684653 (1987-08-01), Taylor et al.
Shih Chuan
Taylor Edward C.
Cseh Carol L.
Eli Lilly and Company
Shah Mukund J.
The Trustess of Princeton University
LandOfFree
N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-gluta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-gluta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-gluta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1426228